ONE colonoscopy significantly reduced colorectal cancer incidence but not mortality over 13 years, in updated findings from ...
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under ...
The procedure might be trendy, but it comes with risks and doesn't address the root causes of digestive problems.
And I’m ready for many more adventures to come.
Objectives: Bidirectional endoscopy is recommended for new-onset iron deficiency anemia (IDA), given the risk of gastrointestinal (GI) cancer. The rate of endoscopic ass ...
Of more than 1,200 cancer patients and survivors surveyed in 2024 , about 47% said they had carried medical debt, with nearly ...
A series of immersive experiences to virtually enter the human body, observe its biological mechanisms, and understand the ...
Lydia O’Connell has experienced the worst of what Crohn’s and other illnesses have thrown at her, but she’s now learning to ...
A single screening colonoscopy reduced colorectal cancer incidence by roughly 30% over 13 years — a meaningful improvement over earlier findings — but failed to produce a statistically significant ...
Lower-volume preparation with 1 L polyethylene glycol (PEG)-ascorbate may be an effective and acceptable option for inpatient ...
Researchers randomly assign more than 100,000 adults without CRC to receive once-only sigmoidoscopy screening or no screening ...
Side effects like nausea, vomiting, diarrhea and constipation are common soon after starting GLP-1s or increasing the drug’s dosage. A nutrient-dense diet and regular exercise a ...